Status:
COMPLETED
Seasonal Influenza Vaccine Effectiveness Study in Kenya
Lead Sponsor:
Gideon Emukule
Collaborating Sponsors:
Kenya Ministry of Health
Kenya Medical Research Institute
Conditions:
Influenza
Influenza Like Illness
Eligibility:
All Genders
6-10 years
Brief Summary
Influenza is an important cause of acute respiratory infections (ARI) worldwide. Seasonal influenza causes an estimated 250,000-500,000 deaths and 3-5 million severe illnesses each year (WHO, 2009), a...
Detailed Description
Vaccine will be donated by Sanofi Pasteur in a quantity large enough to vaccinate the eligible population. Vaccine will be made available to infants from 6 months of age through children up to 10 year...
Eligibility Criteria
Inclusion
- Age 6months -10 years
- Enrolled in the IEIP morbidity study
Exclusion
- Age less than 6 months or greater than or equal to 11 years
- Not enrolled in the IEIP morbidity study
Key Trial Info
Start Date :
June 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 18 2014
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT01432340
Start Date
June 1 2010
End Date
March 18 2014
Last Update
September 20 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
KEMRI/CDC- IEIP surveillance-Asembo
Kisumu, Western, Kenya
2
KEMRI/CDC IEIP surveillance- Kibera
Nairobi, Kenya